MrsGinaRivellini

Davies J, Mossop M, Jonathan I-H, et al.Davies J, Mossop M, Jonathan I-H, Hughes D, Dobra R, Cunanan A, Rosenthal M, Carr S, Ramadan N, Nolan L close, 2024, Chronicity Counts: The Impact of P. aeruginosa, S. aureus, and Co-Infection in Cystic Fibrosis, American Journal of Respiratory and Critical Care Medicine, ISSN:1073-449X

Davies J, Morales S, Alton E, et al.Davies J, Morales S, Alton E, Martin I close, 2023, Lytic bacteriophage is a promising adjunct to common antibiotics across cystic fibrosis clinical strains and culture models of Pseudomonas aeruginosa infection, Antibiotics, Vol:12, ISSN:2079-6382, Pages:1-14

• DOI
• Publisher Web Link
• Open Access Link

Short C, Abkir M, Pinnell S, et al.Short C, Abkir M, Pinnell S, Proctor O, Saunders CJ, Davies JC close, 2022, Migration is not the perfect answer: How the cross-talk error correction for multiple breath nitrogen washout (MBWN2) parameters differs on directly collected vs. legacy data, Pediatric Pulmonology, Vol:58, ISSN:1099-0496, Pages:328-331

• DOI
• Publisher Web Link
• Open Access Link

Davies JC, Scott S, Dobra R, et al.Davies JC, Scott S, Dobra R, Brendell R, Brownlee K, Carr SB, Cosgriff R, Simmonds NJ, London Network of Clinical Trials Accelerator Platform sites, Jahan R, Jones A, Matthews J, Brown S, Galono K, Miles K, Pao C, Shafi N, Watson D, Orchard C, Davies G, Pike K, Shah S, Bossley CJ, Fong T, Macedo P, Ruiz G, Waller M, Baker L close, 2019, Fair selection of participants in clinical trials: The challenge to push the envelope further, Journal of Cystic Fibrosis, Vol:18, ISSN:1569-1993, Pages:e48-e50

• DOI
• Author Web Link
• Open Access Link